Related Experiment Video
Updated: Jan 10, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
Published on: September 30, 2017
[A persistent inflammatory adenopathy… think about tularemia].
Camille Dupuis1, Guillemette Cottin2, Serge De Valliére3,4
1Centre de traitement en réadaptation, Établissements hospitaliers du Nord Vaudois, 1350 Orbe.
Tularemia, a bacterial infection, is expanding geographically in Europe, with Switzerland seeing a near tripling of cases. Early diagnosis and antibiotic treatment are crucial for managing this zoonotic disease, alongside preventive measures.
Area of Science:
- Infectious Diseases
- Epidemiology
- Public Health
Background:
- Tularemia (Francisella tularensis) is a zoonotic bacterial infection with increasing incidence in Europe.
- Geographic expansion and a near tripling of reported cases in Switzerland (2014-2023) highlight a growing public health concern.
- Transmission occurs through various routes including arthropod vectors, direct contact, inhalation, or ingestion.
Purpose of the Study:
- To provide a comprehensive overview of current knowledge on tularemia.
- To offer practical recommendations for the clinical management of tularemia.
- To illustrate management strategies with a real-life clinical case.
Main Methods:
- Review of current literature on tularemia epidemiology, transmission, and clinical presentation.
- Analysis of reported tularemia case incidence trends in Switzerland.
- Case study presentation of a tularemia patient.
Main Results:
- Significant geographic expansion of tularemia in Europe observed.
- Switzerland experienced a near tripling of reported tularemia cases between 2014 and 2023.
- The ulcero-glandular form is most common in Europe; prompt antibiotic therapy is essential.
Conclusions:
- Tularemia poses an increasing threat in Europe, necessitating heightened awareness and surveillance.
- Effective management relies on timely diagnosis, targeted antibiotic therapy, and preventive measures.
- Understanding transmission routes and clinical manifestations is key to controlling the spread of tularemia.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...